Skip to content

13F-HR filed by Healthcare Value Capital, LLC

Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 26 holding rows worth $59,453,000.

Accession
0000919574-20-003506
Filed
2020-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2020

A holdings report, 26 entries on the cover page, a total value of $59,453,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $59,453,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AbbVie,Inc.00287Y109COM50,000$3,810,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR100,000$3,789,000thousands by filing date
Gilead Sciences,Inc.375558103COM50,000$3,738,000thousands by filing date
Gilead Sciences,Inc.375558103COM50,000$3,738,000thousands by filing datecall
INVESCO QQQ TRUST SERIES 174347B268ULTRAPRO SHORT S150,000$3,618,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM75,000$3,596,000thousands by filing date
MCKESSON CORP COM58155Q103Stock25,000$3,382,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR75,000$3,351,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW25,000$3,160,000thousands by filing date
DIREXION SHARES ETF TRUST25459W862DA 500 BU 3X ETF120,000$3,126,000thousands by filing datecall
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock30,000$2,992,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM30,000$2,694,000thousands by filing date
CENCORA INC COM03073E105Stock30,000$2,655,000thousands by filing date
TYME TECHNOLOGIES INC COM90238J103Stock2,175,000$2,393,000thousands by filing date
MENLO THERAPEUTICS INC586858102COM850,000$2,278,000thousands by filing date
INVESCO QQQ TRUST SERIES 174347B268ULTRAPRO SHORT S75,000$1,809,000thousands by filing datecall
CLOVIS ONCOLOGY INC189464100COM250,000$1,590,000thousands by filing date
CVS Health Corporation126650100COM25,000$1,483,000thousands by filing date
ANTARES PHARMA INC036642106COM500,000$1,180,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM25,000$1,144,000thousands by filing date
PROSHARES TR ULTSH NASD BIOT74347B789CEF75,000$1,058,000thousands by filing datecall
AMARIN CORP PLC023111206SPONS ADR NEW200,000$800,000thousands by filing datecall
CLOVIS ONCOLOGY INC189464100COM100,000$636,000thousands by filing datecall
ADAMAS PHARMACEUTICALS INC00548A106COM200,000$578,000thousands by filing datecall
VIKING THERAPEUTICS INC92686J106COM100,000$468,000thousands by filing datecall
GREENLANE HLDGS INC395330103CL A225,000$387,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-003506this filing2020-05-15acceptance time not in the bulk data set